Characterization of Mesenchymal Stem Cells obtained from human lungs with and without Idiopathic Pulmonary Fibrosis
Andreas Jahn(University of Washington), Ernest Sala(Hospital Universitario Son Espases), Carlos Río(Health Research Institute of the Balearic Islands), Orlando Gigirey(Hospital Universitario Son Espases), Pere Joan Pont(Health Research Institute of the Balearic Islands), Ángel Francisco Carvajal(Hospital Universitario Son Espases), María Molina‐Molina(Instituto de Salud Carlos III), Josep Mercader(Fundació Universitat-Empresa de les Illes Balears), Cristina Gómez(Hospital Universitario Son Espases), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Julio Velasco(Hospital Universitario Son Espases), Cristina Villena(Hospital Universitario Son Espases)
Cited by 2
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
|Journal of Clinical Investigation|2009|556
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343